- PCI Biotech second half 2023 interim results
- PCI Biotech: Invitation to second half interim 2023 results presentation
- PCI Biotech initiates field testing of its proprietary technology for gene therapy manufacturing
- PCI Biotech: European patent for mRNA delivery with fimaNAc
- PCI Biotech: Employee share option scheme
- PCI Biotech: Write-down of share capital registered
- PCI Biotech first half 2023 interim results
- PCI Biotech: Invitation to first half interim 2023 results presentation
- Minutes from Annual General Meeting 2023
- Disclosure of voting rights for Chairman of the Board
More ▼
Key statistics
On Wednesday, PCI Biotech Holding ASA (PCIB:OSL) closed at 1.70, 41.50% above the 52 week low of 1.20 set on Oct 11, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.58 |
---|---|
High | 1.70 |
Low | 1.58 |
Bid | 1.70 |
Offer | 1.74 |
Previous close | 1.65 |
Average volume | 94.37k |
---|---|
Shares outstanding | 37.33m |
Free float | 28.39m |
P/E (TTM) | -- |
Market cap | 63.38m NOK |
EPS (TTM) | -0.5443 NOK |
Data delayed at least 15 minutes, as of Mar 27 2024.
More ▼